SCHEMBL4206643

SCHEMBL4206643

COc1cc2c(Cc3cccc(Br)c3)nc3[nH]ncc3c2cc1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.44
ADORA1 P30542 1/20 0.44
PLK4 O00444 1/20 0.44
PAK4 O96013 1/20 0.44
MAPT P10636 3/20 0.40
PDE3B Q13370 2/20 0.40
PDE3A Q14432 2/20 0.40
TP53 P04637 1/20 0.40
TNF P01375 1/20 0.39
FBP1 P09467 2/20 0.38
ABCG2 Q9UNQ0 2/20 0.38
TDO2 P48775 1/20 0.38
EGFR P00533 4/20 0.38
CYP3A4 P08684 4/20 0.38
ALDH1A1 P00352 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
CYP2C9 P11712 3/20 0.38
TSHR P16473 3/20 0.38
CYP2C19 P33261 3/20 0.38
MAPK1 P28482 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4197701 0.82 PARP1 (0.40) MAPTPDE3BPDE3ACYP3A4ALDH1A1
SCHEMBL4191236 0.80 PLK4 (0.42) PLK4PAK4MAPTPDE3BPDE3A
SCHEMBL4202705 0.77 EGFR (0.42) MAPTPDE3BPDE3AFBP1EGFR
SCHEMBL4205040 0.76 PTPN7 (0.39) MAPTPDE3BPDE3AEGFRCYP3A4
SCHEMBL24000347 0.75 CYP3A4 (0.62) ADORA2AADORA1CYP3A4CYP2C9TSHR
SCHEMBL30450480 0.75 PDE10A (0.45) ADORA2AADORA1MAPTPDE3BPDE3A
SCHEMBL30088826 0.75 CYP3A4 (0.62) ADORA2AADORA1CYP3A4CYP2C9TSHR
SCHEMBL6273407 0.71 EGFR (0.57) MAPTFBP1ABCG2EGFRCYP3A4
SCHEMBL5569386 0.69 PARP1 (0.47) PLK4PAK4CYP3A4ALDH1A1SMN1; SMN2
SCHEMBL11971402 0.68 PDE10A (0.41) ADORA2AADORA1PLK4MAPTEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1648455-A4 ANAPLASTIC LYMPHOMA KINASE MODULATORS AND METHODS OF USE EXELIXIS INC (US) 2009-03-04 EP disclosed
EP-1648455-A2 ANAPLASTIC LYMPHOMA KINASE MODULATORS AND METHODS OF USE Exelixis, Inc. (US) 2006-04-26 EP disclosed
WO-2005009389-A2 ANAPLASTIC LYMPHOMA KINASE MODULATORS AND METHODS OF USE EXELIXIS, INC. (US) 2005-02-03 WO disclosed